Stocks were again seeking direction on Thursday morning after recently hitting new highs again. If there is one trend that keeps being proven it is that investors will buy stocks on each and every market pullback. Investors and traders also want to buy value stocks or overlooked growth stories when they can. 24/7 Wall St. reviews dozens of new analyst research reports each morning of the week to find new investing and trading ideas for its readers. Some of these research reports cover stocks to Buy. Others cover stocks to sell or stocks to avoid.

These are this Thursday’s top analyst upgrades, downgrades and initiations from 24/7 Wall St.

Castlight Health Inc. (NYSE: CSLT) was downgraded to Hold from Buy at Canacord Genuity. The firm cut the price target to $10 from $18, after indicating that soft bookings give it pause and that there is just no room for any slip-up at the current valuation.

Coach Inc. (NYSE: COH) was raised to Buy from Hold at Topeka Capital Markets.

Endo International PLC (NASDAQ: ENDP) was started as Buy at Citigroup.

ALSO READ: Analyst Has 3 Oil Stocks to Buy Now, and 2 to Sell

EOG Resources Inc. (NYSE: EOG) was downgraded to Neutral from Buy at Citigroup.

Garmin Ltd. (NASDAQ: GRMN) was raised to Buy from Neutral at Bank of America Merrill Lynch and the price objective was raised to $65 from $60 after this week’s sell-off. RBC maintained its Outperform rating and raised its price target to $67 from $62.

Hologic Inc. (NASDAQ: HOLX) was raised to Buy from Hold and the price target was raised to $37 from $29 at Canaccord Genuity.

Huntsman Corp. (NYSE: HUN) was downgraded to Neutral from Buy at Citigroup.

Intelsat S.A. (NYSE: I) beat earnings handily but issued guidance under expectations. It was downgraded to Neutral from Buy at UBS, and it was cut to Underweight from Neutral at J.P. Morgan.

Pharmacyclics Inc. (NASDAQ: PCYC) has dueling calls on Thursday. It was raised to Buy from Neutral at Nomura but downgraded to Neutral from Overweight at J.P. Morgan.

Potbelly Corp. (NASDAQ: PBPB) was downgraded to Underperform from Neutral with a $17 price objective (versus a $16.56 close) at Merrill Lynch.

Sanofi (NYSE: SNY) upgraded to Buy from Neutral at Merrill Lynch.

ALSO READ: 4 Blue-Chip Biotech Stocks to Buy for the Rest of 2015

SolarCity Corp. (NASDAQ: SCTY) was indicated 3% lower after earnings. So far, we have seen slight target hikes and Buy ratings reiterated at Merrill Lynch and at Canaccord Genuity.

Valero Energy Corp. (NYSE: VLO) was raised to Buy from Hold at Deutsche Bank.

Meet the 2015 Warren Buffett stock holdings, as many have changed in this last quarter.

In case you missed Wednesday’s top analyst upgrades and downgrades, they included Amarin, CenturyLink, Legg Mason, Rackspace, Transocean, Valero Energy and a dozen more.